BindingDB logo
myBDB logout

12 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27075367 55 Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2.EBI Bayer Pharma AG
26101576 12 Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2.EBI AbbVie Inc
25406853 72 Selective inhibitors of protein methyltransferases.EBI Icahn School of Medicine at Mount Sinai
25746813 37 SAH derived potent and selective EZH2 inhibitors.EBI Pfizer Inc
25032507 43 Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.EBI University of North Carolina at Chapel Hill
22975593 62 Oncoepigenomics: making histone lysine methylation count.EBI TBA
26985287 46 Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 Inhibitor.EBI Epizyme Inc.
29320176 8 Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT).EBI Icahn School of Medicine at Mount Sinai
17034119 24 Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis.BDB Wyeth Research
15916422 42 Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.BDB University of Washington at Seattle